Literature DB >> 16037

Intrarenal dynamics in the pathogenesis and prevention of acute urate nephropathy.

J D Conger, S A Falk.   

Abstract

Tubular fluid flow, urine osmolality, and pH were selectively altered to determine the relative protective roles of these factors in a rat model of acute urate nephrophathy. Various prehyper uricemic conditions were established in five groups of animals: (a) normopenic Wistar rats given no pretreatment (Group I); (b) Wistar rats given acetazolamide, 20 mg/kg, and isotonic NaHCO3 to produce urine alkalinization (Group II); (c) Wistar rats in which a moderate diuresis, similar to that observed in Group II but without urine alkalinization, was induced with furosemide, 2 mg/kg (Group III); (d) Wistar rats in which a high-flow solute diuresis was induced with furosemide, 15 mg/kg (Group IV); (e) Brattleboro rats, homozygous for pituitary diabetes insipidus, that had a spontaneous high-flow water diuresis (Group V). A comparable level of hyperuricemia (19.4+/-2.2 mg/100 ml) was achieved in all animals with intravenous urate infusion. Clearance and micropuncture studies were performed before and 1 h after induction of hyperuicemia. Group I rats had mean falls in renal plasma flow and glomerular filtration rate of 83 and 86%, respectively; nephron filtration rate decreased 66%, and tubular and microvascular pressures increased twofold. In Group II there were 45 and 47% declines in renal plasma flow and glomerular filtration rate, respectively, a 66% fall in nephron filtration rate, and a 30% increase in tubular and vascular pressures. Moderate amounts of urate were seen in the kidneys. Group III had changes in renal function identical to Group II suggesting that the moderate prehyperuricemic diuresis in the latter group and not urine alkalinization produced the partial protection observed. Groups IV and V were completely and comparably protected with renal function studies unchanged from controls. It is concluded that high tubular fluid flow, whether induced by a solute or water diuresis, is the primary mechanism of protection in acute urate nephropathy. At most, urine alkalinization plays a minor preventive role.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 16037      PMCID: PMC372286          DOI: 10.1172/JCI108700

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  18 in total

1.  Hemodialysis for acute anuric uric acid nephropathy.

Authors:  S M Steinberg; M A Galen; J M Lazarus; E G Lowrie; C L Hampers; N Jaffe
Journal:  Am J Dis Child       Date:  1975-08

Review 2.  RENAL COMPLICATIONS OF NEOPLASTIC DISEASE.

Authors:  E FREI; C J BENTZEL; R RIESELBACH; J B BLOCK
Journal:  J Chronic Dis       Date:  1963-07

3.  ACUTE URIC ACID NEPHROPATHY IN LEUKEMIA. REPORT OF A CASE TREATED WITH PERITONEAL DIALYSIS.

Authors:  L R WEINTRAUB; J A PENNER; M C MEYERS
Journal:  Arch Intern Med       Date:  1964-01

4.  URIC ACID EXCRETION AND RENAL FUNCTION IN THE ACUTE HYPERURICEMIA OF LEUKEMIA. PATHOGENESIS AND THERAPY OF URIC ACID NEPHROPATHY.

Authors:  R E RIESELBACH; C J BENTZEL; E COTLOVE; E FREI; E J FREIREICH
Journal:  Am J Med       Date:  1964-12       Impact factor: 4.965

5.  EXPERIMENTAL URATE NEROPATHY: STUDIES OF THE DISTRIBUTION OF URATE IN RENAL TISSUE.

Authors:  F H EPSTEIN; G PIGEON
Journal:  Nephron       Date:  1964       Impact factor: 2.847

6.  Anuria complicating the treatment of leukemia.

Authors:  R A KRITZLER
Journal:  Am J Med       Date:  1958-10       Impact factor: 4.965

7.  A modification of the fluorescence method for micro-inulin determinations.

Authors:  J D Conger; H N Rhoads; S N Christie; T J Burke
Journal:  Kidney Int       Date:  1975-11       Impact factor: 10.612

8.  Hyperuricemic acute renal failure.

Authors:  C M Kjellstrand; D C Cambell; B von Hartitzsch; T J Buselmeier
Journal:  Arch Intern Med       Date:  1974-03

9.  Urate deposition disease. How is it regulated and how can it be modified?

Authors:  J R Klinenberg; R Bluestone; L Schlosstein; J Waisman; M W Whitehouse
Journal:  Ann Intern Med       Date:  1973-01       Impact factor: 25.391

10.  The influence of the extracellular fluid volume on the tubular reabsorption of uric acid.

Authors:  E J Weinman; G Eknoyan; W N Suki
Journal:  J Clin Invest       Date:  1975-02       Impact factor: 14.808

View more
  19 in total

Review 1.  Tumor lysis syndrome: A clinical review.

Authors:  Aibek E Mirrakhimov; Prakruthi Voore; Maliha Khan; Alaa M Ali
Journal:  World J Crit Care Med       Date:  2015-05-04

Review 2.  A focused review of the pathogenesis, diagnosis, and management of tumor lysis syndrome for the interventional radiologist.

Authors:  Marcia Friedman; Pritesh R Patel; Damiano Rondelli
Journal:  Semin Intervent Radiol       Date:  2015-06       Impact factor: 1.513

3.  Febuxostat and tumor lysis syndrome: an indication that remains unclear.

Authors:  F Vincent; A Dupré; C Mousseaux; C Bornstain; M Darmon
Journal:  Int J Clin Oncol       Date:  2016-12-01       Impact factor: 3.402

Review 4.  Kidney diseases associated with haematological cancers.

Authors:  Anirban Ganguli; Deirdre Sawinski; Jeffrey S Berns
Journal:  Nat Rev Nephrol       Date:  2015-06-02       Impact factor: 28.314

Review 5.  The tumor lysis syndrome.

Authors:  Scott C Howard; Deborah P Jones; Ching-Hon Pui
Journal:  N Engl J Med       Date:  2011-05-12       Impact factor: 91.245

Review 6.  Tumor lysis syndrome: new challenges and recent advances.

Authors:  F Perry Wilson; Jeffrey S Berns
Journal:  Adv Chronic Kidney Dis       Date:  2014-01       Impact factor: 3.620

7.  Understanding tumor lysis syndrome.

Authors:  Lara Zafrani; Emmanuel Canet; Michael Darmon
Journal:  Intensive Care Med       Date:  2019-09-13       Impact factor: 17.440

8.  Rasburicase for hyperuricemia in hemolytic uremic syndrome.

Authors:  Alisa A Acosta; Ronald J Hogg
Journal:  Pediatr Nephrol       Date:  2011-11-17       Impact factor: 3.714

Review 9.  Acute renal failure: the glomerular and tubular connection.

Authors:  J E Bird; R C Blantz
Journal:  Pediatr Nephrol       Date:  1987-07       Impact factor: 3.714

10.  Diagnosis, treatment and follow-up of 25 patients with melamine-induced kidney stones complicated by acute obstructive renal failure in Beijing Children's Hospital.

Authors:  Qiang Sun; Ying Shen; Ning Sun; Gui Ju Zhang; Zhi Chen; Jian Feng Fan; Li Qun Jia; Hong Zhan Xiao; Xu Ran Li; Birgit Puschner
Journal:  Eur J Pediatr       Date:  2009-10-21       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.